China Tongfu (01763) announced that the subsidiary, China Nuclear Chengying (Xi'an) Medical Equipment Co., Ltd.
Zhongtong Finance APP News: China Tongfu (01763) announced that its subsidiary, China Nuclear Chengying (Xi'an) Medical Equipment Co., Ltd. (China Nuclear Chengying), successfully obtained the National Medical Products Administration (NMPA) medical device registration certificate for the new gamma beam stereotactic radiotherapy system. The product digitizes and intelligently manages the device by integrating information flows in the four processes of diagnosis, imaging, planning and treatment, and combining advanced treatment control system TCS, treatment planning system TPS, and image guidance system IGS. The product is equipped with CBCT image guidance system registration and six-dimensional bed automatic correction function to ensure the accuracy of radiotherapy. The product has ultra-high dose rate and powerful automation capability, which can significantly improve patient treatment efficiency and shorten treatment time. The professional head-body integrated knife design makes the indication range wider and the functions more powerful.
The group is the only supplier of domestic medical cobalt-60, and the successful registration of this product is an important achievement of the group's "source equipment" collaborative model. Riding on the group's domestic cobalt-60 radiation source express, China Nuclear Chengying will always adhere to the clinical application-oriented, and take the responsibility of meeting clinical needs, so that more Chinese cancer patients can use good radiotherapy equipment, and promote the localization and popularization of high-end radiotherapy equipment. The launch of this product will contribute to the realization of the strategic goal of "Healthy China 2030" and the improvement of national health security.